NHS lands breakthrough in global battle against superbugs

  17 June 2022

The NHS is set to roll out two ‘superbug’ busting drugs through a world-first, pioneering subscription deal that will help tackle antimicrobial resistance, the head of the NHS announced today.

The deal, initially for two antimicrobial drugs, means patients with serious infections that have evolved so much that antibiotics and other current treatments are no longer effective, can be given a potentially life-saving alternative.

These drugs will provide a lifeline to patients with life-threatening infections like sepsis, hospital or ventilator pneumonia and blood stream infection, with increasing numbers of people developing drug resistance as germs evolve to become resistant to current antibiotics.

 

Further reading: NHS
Author(s): NHS
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed